Revvity (RVTY) News
NYSE: RVTYIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
154.18+2.02 (+1.33%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
RVTY news summary
We found 3 recent headlines mentioning Revvity (RVTY): 0 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, RVTY is up 1.33% at $154.18. The most recent story, "Invesco S&P 500 Equal Weight ETF Experiences Big Outflow", was published by Nasdaq on Sep 30, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Revvity headlines
- Invesco S&P 500 Equal Weight ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected…NasdaqRSP, P, ILMN, RVTY
- Here's Why You Should Retain Revvity Stock in Your Portfolio for NowRVTY's diagnostics growth, AI-driven demand and life sciences expansion support its outlook, though China and margin pressures pose near-term challenges.NasdaqRVTY, ISRG, GMED, VCYT
- Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?Revvity's raised 2026 outlook, Diagnostics growth and stronger cash flow brighten the setup, but premium valuation and software risks call for selectivity.NasdaqRVTY, DHR, MEDP